Liquid Biopsy Market

액체 생검 시장 조사 보고서 - 2035년까지의 글로벌 전망
ID: MRFR/HC/0239-CR
171 Pages
Rahul Gotadki, Kinjoll Dey
Last Updated: July 20, 2026
Liquid Biopsy Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)10.52%
2024 Market Size$ 9.1 Billion
2025 Market Size$ 10.06 Billion
2035 Market Size$ 27.34 Billion
Key Players
Companies such as Guardant Health
Exact Sciences
GRAIL
Freenome
Biocept
Sysmex Corporation
Opportunities
  • Rising Incidence of Cancer

Liquid Biopsy Market 요약

Liquid Biopsy Market 시장의 주요 기업은 다음과 같습니다

향후 전망

Liquid Biopsy Market 향후 전망

보고서 범위

FAQs

What is the current valuation of the Liquid Biopsy Market as of 2024?
It was valued at 9.1 USD Billion in 2024.
What is the projected market size for the Liquid Biopsy Market by 2035?

The market is projected to reach 27.34 USD Billion by 2035.

What is the expected CAGR for the Liquid Biopsy Market during the forecast period 2025 - 2035?
The expected CAGR for during 2025 - 2035 is 10.52%.
Which application segment is anticipated to dominate the Liquid Biopsy Market?

The Oncology application segment is expected to grow from 4.5 USD Billion to 13.5 USD Billion by 2035.

How does the market for Non-Oncology applications compare to Prenatal Testing?

The Non-Oncology segment is projected to expand from 2.0 USD Billion to 6.0 USD Billion, while Prenatal Testing is expected to grow from 1.0 USD Billion to 3.0 USD Billion.

What are the leading sample types utilized in the Liquid Biopsy Market?

Blood is anticipated to be the leading sample type, growing from 3.5 USD Billion to 10.5 USD Billion by 2035.

Which technology segment is likely to see the most growth in the Liquid Biopsy Market?

Next Generation Sequencing is projected to increase from 2.73 USD Billion to 8.12 USD Billion during the forecast period.

What role do hospitals play in the Liquid Biopsy Market?

Hospitals are expected to grow from 2.73 USD Billion to 8.12 USD Billion, indicating their significant role as end users.

Who are the key players in the Liquid Biopsy Market?

Key players include Guardant Health, Exact Sciences, GRAIL, Freenome, and Roche Diagnostics.

What is the anticipated growth for the Diagnostic Laboratories segment?

The Diagnostic Laboratories segment is expected to grow from 2.27 USD Billion to 6.81 USD Billion by 2035.

저자
Author
Author Profile
Rahul Gotadki LinkedIn
Research Manager
He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.
Co-Author
Co-Author Profile
Kinjoll Dey LinkedIn
Senior Research Analyst
He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

Research Approach

Research Methodology on Liquid Biopsy Market Overview

Introduction

The research methodology for the “Liquid Biopsy Market - Global Analysis and Forecasts” report is presented in this section. This research aims to provide in-depth insights into the global liquid biopsy market, by analyzing its current and projected performance concerning competitive market forces. This report provides an overview of the industry, market drivers and inhibitors influencing the market growth, competitive dynamics and key chapters of the market in terms of market segmentation and applications.

Research Approach

In order to collect information on market trends, drivers and inhibitors, the research process includes extrapolating the data and insights derived from second-party resources such as published reports, corporate websites, and public datasets. The prognosis of the global liquid biopsy market is established by balancing the vital qualitative and quantitative information which is obtained through primary interviews with Market Experts and Thought Leaders, as well as via extensive literature reviews including secondary sources such as directories, industry journals, white papers, technical papers, press releases, corporate annual reports from top players.

Moreover, market forecasts and projections are established by using advanced econometric techniques and models. The research process is divided into five sections – Primary & Secondary Exploration, Mapping of Market Opportunities, Market Assessments & Projections and Validation of Model Assumptions.

Scope of the Report

The report includes the landscape of the global liquid biopsy market, its size by value, by region and by end-user, competitive landscape and competitive strategies adopted by key players, market dynamics such as drivers, restraints, opportunities and challenges, new technological advancements and recent launches and future market trends. The notable market players included in the report comprise Genomic Health Inc., Life Technologies Corporation, Biocept Inc., Biodesix Inc., Cepheid, Cynvenio Biosystems Inc., Exosome Life Sciences, HTG, MDxHealth Ltd., Myriad Genetics Inc., and Trovagene Inc. In all, 17 company profiles have been included in the report.

Research Methodology

The research methodology for the liquid biopsy market is based on both primary and secondary research. For the primary research, a structured questionnaire is sent to industry experts, including key opinion leaders and thought leaders, who provided their insights and views on the market. In addition, macro- and micro-economic indicators of the industry are considered for arriving at the expected market growth during the forecast period. The secondary research is done using extensive research methodologies and in-depth analysis of published market reports and content from paid databases, journals and other third-party resources. The market data is also validated with proprietary analytics tools and models.

The market is segmented into product types, applications, end-users, geographies and key countries and stakeholders. Primary interviews are conducted to ascertain the market estimates and confirm the assumptions based on secondary and primary research. The report covers a geographic segmentation of the liquid biopsy market along with competitor analysis for key countries/regions such as North America (US, Canada, Mexico and the Rest of North America), Europe (The UK, Germany, France, Rest of Europe), Asia-Pacific (India, China, Japan, Rest of Asia Pacific) and Rest of the world (Middle East & Africa, Latin America).

Market Estimation

The global liquid biopsy market is estimated considering historical data and various market dynamics such as market drivers, opportunities and challenges. Thereafter, calculated values have been derived through an exhaustive triangulation method. All these factors are studied, analyzed, considered and weighted to arrive at the estimated values, which help to forecast the market position in terms of CAGR, size and other important parameters.

Data Sources

The data points considered to come up with the market estimates and forecasts include secondary research, databases and primary research (which includes interviews and surveys). The data points were aggregated and the resultant values were checked and validated using proprietary analytics models.

Customization

The report can be customized as per the requirements of the clients. Based on detailed analysis and insights into the market, customized deliveries on the research report are provided including company-specific analysis, regional-specific analysis and segment-specific analysis.

무료 샘플 다운로드

이 보고서의 무료 샘플을 받으려면 아래 양식을 작성하십시오

Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.